Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2010 /
New research potential at The Christie

7th - 10th Nov 2010

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.11.10
Views: 5931

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

Dr Paul Lorigan explains what the construction of the new patient treatment centre at The Christie NHS foundation Trust will mean to clinicians. The new facilities will reduce waiting times, allow the delivery of the very best treatments to more patients more efficiently and the development of innovative new treatments. The new centre will be divided into three parts: the chemotherapy facility, the clinical trial research facility and the private patient facility. Dr Lorigan explains how the new research facility will significantly increase the potential for drug development, especially in the field of personalised medicine and talks about the research planned in relation to melanoma and lung cancer.


Radiotherapy NCRI 2010

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation